| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI118167 |
| P8608 | Fatcat ID | release_binyucvtfrfxncsy3mytnnx4uu |
| P953 | full work available at URL | http://www.jci.org/articles/view/118167/files/pdf |
| https://europepmc.org/articles/PMC185754 | ||
| https://europepmc.org/articles/PMC185754?pdf=render | ||
| P932 | PMC publication ID | 185754 |
| P698 | PubMed publication ID | 7657807 |
| P2093 | author name string | S. Nakamura | |
| T. Kishimoto | |||
| T. Taga | |||
| K. Murakami-Mori | |||
| P2860 | cites work | Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells | Q24305320 |
| Neuropoietic cytokines in the hematopoietic fold | Q24322963 | ||
| Molecular cloning and expression of an IL-6 signal transducer, gp130 | Q24328945 | ||
| Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6 | Q24337530 | ||
| Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells | Q24627585 | ||
| Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M | Q24633689 | ||
| Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes | Q28250222 | ||
| Identification and characterization of cellular receptors for the growth regulator, oncostatin M | Q28251326 | ||
| Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 | Q28279735 | ||
| Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M | Q28284457 | ||
| The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor | Q28284469 | ||
| Regulation of IL-6 expression by oncostatin M | Q28308106 | ||
| LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
| AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6 | Q33602539 | ||
| The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome | Q34693731 | ||
| Oncostatin M is a mitogen for rabbit vascular smooth muscle cells | Q36076266 | ||
| Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication | Q36355310 | ||
| Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. | Q36362934 | ||
| Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130 | Q36362977 | ||
| Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130 | Q37304521 | ||
| Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth | Q40339285 | ||
| Interactions between oncostatin M and the IL-6 signal transducer, gp130. | Q41470736 | ||
| Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma. | Q41551727 | ||
| Kaposi's sarcoma in organ transplant recipients: report of 20 cases | Q41593468 | ||
| Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. | Q41607790 | ||
| Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism. | Q41665039 | ||
| Prevalence of Kaposi's sarcoma among patients with AIDS. | Q44775763 | ||
| Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex | Q46576000 | ||
| Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs | Q46643016 | ||
| Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. | Q52255154 | ||
| Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. | Q52833089 | ||
| AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. | Q54565305 | ||
| Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. | Q55242415 | ||
| Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro | Q67895364 | ||
| Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells | Q70363599 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| cell growth | Q189159 | ||
| Kaposi's sarcoma | Q725345 | ||
| antibody | Q79460 | ||
| interleukin-6 | Q24724988 | ||
| Gene expression | Q112947517 | ||
| P304 | page(s) | 1319-27 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies | |
| P478 | volume | 96 |
| Q54588886 | Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses. |
| Q35885806 | Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? |
| Q48506360 | Contradictory Concepts in the Etiology and Regression of Kaposi's Sarcoma. The Ferenc Györkey Memorial Lecture |
| Q42811240 | Cross-talk among gp130 cytokines in adipocytes |
| Q41474260 | Cytokines and the hepatic acute phase response |
| Q40815412 | Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells. |
| Q24313382 | Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation |
| Q36897350 | Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. |
| Q35746838 | Exclusive neutrophil recruitment with oncostatin M in a human system |
| Q77903163 | General classes and functions of four-helix bundle cytokines |
| Q35876140 | Human herpesvirus 8 encodes a homolog of interleukin-6. |
| Q36437751 | Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin |
| Q36863399 | Isolation and characterization of the human gp130 promoter. Regulation by STATS. |
| Q35077642 | Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion |
| Q41125455 | Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. |
| Q61641140 | Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents |
| Q48502816 | Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes |
| Q73634638 | Oncostatin M and transforming growth factor-beta 1 induce post-translational modification and hyaluronan binding to CD44 in lung-derived epithelial tumor cells |
| Q35110909 | Pathogenesis and manifestations of human herpesvirus-8-associated disorders |
| Q37373492 | Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow |
| Q28214190 | The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases |
| Q41387021 | The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines |
| Q35917368 | Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders |
Search more.